http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6229545-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9822bceff022feda91b10019125e70f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-18
filingDate 1985-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1675d2622ac1716cff4c63e849e68ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e52ecde6a64d6f639013832142f314b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d891ad7bcbadc770040baefecc2b6bd0
publicationDate 1987-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6229545-A
titleOfInvention Tetrahydronaphthalene derivative
abstract NEW MATERIAL:A tetrahydronaphthalene derivative expressed by formula I (R 1 and R 2 are lower alkoxy; n is 0 or 1). n EXAMPLE: 2Z-(2-Hydroxyethylidene)-5,8-dimethoxy-1,2,3,4-tetrahydrofuran. n USE: A medicine and raw material capable of synthesizing bicyclic-hydroxyketones expressed by formula II which are synthetic intermediate for 4- demethoxydaunorubicin which is a nonnatural type anthracyclin based antibiotic substance attracting attention by a wide carcinostatic spectrum and powerful carcinostatic activity in a short step. n PREPARATION: A homoallyl alcohol expressed by formula III is acetylated to give a compound expressed by formula IV, which is then converted into a dienol acetate expressed by formula V. The resultant dienol acetate expressed by formula V is then subjected to 1,4-hydrogenation reaction to afford an allyl acetate expressed by formula VI, which is further hydrolyzed to give the compound expressed by formula I (n is 0). The resultant compound expressed by formula I (n is 0) is then subjected to asymmetric epoxidation reaction to afford the compound expressed by formula I (n is 1). n COPYRIGHT: (C)1987,JPO&Japio
priorityDate 1985-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87105440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226950277

Total number of triples: 22.